Literature DB >> 9037222

A double-blind study of perioperative steroid requirements in secondary adrenal insufficiency.

J V Glowniak1, D L Loriaux.   

Abstract

BACKGROUND: Patients treated long-term with supraphysiologic doses of glucocorticoids experience secondary adrenal insufficiency and are routinely given large doses of steroids in the perioperative period to prevent hypotension. Because the dose of steroids required to prevent hypotension is not known, we conducted a randomized, double-blind study to determine whether patients treated long-term with glucocorticoids actually require increased steroids in the perioperative period.
METHODS: Patients who had been taking at least 7.5 mg prednisone daily for several months and had secondary adrenal insufficiency as defined by adrenocorticotropic hormone testing formed the study population. Patients were randomized to two groups. One group received perioperative injections of saline solution alone; the other received perioperative saline solution and cortisol. All patients received their usual daily prednisone dose throughout the study.
RESULTS: Six patients were in the steroid-treated group and 12 were in the saline-treated group. Most subjects underwent major operations such as joint replacements, abdominal operations, and miscellaneous other procedures. Two patients had hypotension, one in each group. Hypotension resolved with volume replacement in both patients. The average pulse rates and blood pressures were similar in both groups during the perioperative period.
CONCLUSIONS: Patients with secondary adrenal insufficiency do not experience hypotension or tachycardia caused by inadequate glucocorticoid levels when given only their daily dose of steroids for surgical procedures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037222     DOI: 10.1016/s0039-6060(97)90280-4

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  13 in total

1.  Perioperative management of patients with connective tissue disease.

Authors:  Susan M Goodman; Mark P Figgie; C Ronald Mackenzie
Journal:  HSS J       Date:  2010-08-17

Review 2.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

Review 3.  Stress Dose Steroids: Myths and Perioperative Medicine.

Authors:  C Ronald MacKenzie; Susan M Goodman
Journal:  Curr Rheumatol Rep       Date:  2016-07       Impact factor: 4.592

Review 4.  Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management.

Authors:  Susan M Goodman
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

Review 5.  Perioperative infection in the patient with rheumatic disease.

Authors:  Andy O Miller; Barry D Brause
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

Review 6.  [Adrenal cortex and steroids. Supplementary therapy in the perioperative phase].

Authors:  A S Milde; B W Böttiger; M Morcos
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

Review 7.  Perioperative stress-dose steroids.

Authors:  Kristin N Kelly; Bastian Domajnko
Journal:  Clin Colon Rectal Surg       Date:  2013-09

8.  Perioperative management of medications used in the treatment of rheumatoid arthritis.

Authors:  Carla R Scanzello; Mark P Figgie; Bryan J Nestor; Susan M Goodman
Journal:  HSS J       Date:  2006-09

Review 9.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

10.  Selective use of peri-operative steroids in pituitary tumor surgery: escape from dogma.

Authors:  Jacqueline Regan; Joseph Watson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.